AzTrials
AzTrials

Occupational ExposureNCT05507944

FeNO Hairdressers Pilot

An observational study of Occupational Exposure and Environmental Exposure, run by Oslo University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A 5-day cohort diurnal FeNO study of exposed and unexposed to airway irritants during hair treatments and commuting. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Occupational Exposure, Environmental Exposure
What is being tested?
FeNO measurement
How many people
30 participants
Where
1 siteNorway
Study dates
15 Sep 2022to 15 Nov 2022
How long will I take part?
6 Days
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Employed as hairdressers or at Oslo University Hospital as healthcare workers.

Who may be able to join

  • have given informed consent.
  • employed as hairdressers or at Oslo University Hospital as healthcare workers.
  • scheduled work for at least 3 hours daily for 5 days in the study week.

Who cannot join

  • lung disease.
  • active smoker.

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Oslo University Hospital

    Oslo, 0139

Other trials in Norway

About this study

Official title: Fraction of Exhaled Nitric Oxide (FeNO) in an Occupational Cohort of Hairdressers

A 5-day cohort diurnal FeNO study of exposed and unexposed to airway irritants during hair treatments and commuting.

Read the detailed description

The project aims to increase the knowledge of daily variations in FeNO with emphasis on exposure of airway irritants during hairdressing treatments in an occupational setting and commuting. Daily measurements of FeNO before and after workplace exposure in an exposed and an unexposed cohort during a workweek (Monday to Saturday) will indicate patterns of proinflammatory responses in a dose-dependent manner. These may or may not be indicative of an increased risk for airway related disease. Results may be used for further studies of occupational hygiene, airway related disease and identification of endogenous volatile organic compounds during proinflammatory responses.

Being tested
FeNO measurement
Keywords
Airway irritants

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FeNO measurementDiagnostic test

    Diurnal measurements before work and at 3 hours after work start.

Study groups in NCT05507944
Study groupRoleWhat they receive
Healthcare workers at Oslo University HospitalOccupational control. Environmental exposure during commuting.
Receives: Diagnostic Test: FeNO measurement
HairdressersOccupational exposure for airway irritants during hairdressing. Environmental exposure during commuting.
Receives: Diagnostic Test: FeNO measurement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Daily FeNO (ppb measured by Niox Vero) increase after occupational exposure.

    At start of work and after 3 hours. Hardressers vs. Health care workers.

    Measured: 1 day.

  2. Daily FeNO (ppb measured by Niox Vero) increase after enviromental exposure during commuting.

    At start of work and after 3 hours. Subgrouped after way of commuting.

    Measured: 1 day.

  3. Diurnal FeNO (ppb measured by Niox Vero) variations during a work week after occupational exposure.

    At start of work and after 3 hours. Hardressers vs. Health care workers.

    Measured: 6 days

  4. Diurnal FeNO (ppb measured by Niox Vero) variations during a work week after environmental exposure during commuting.

    At start of work and after 3 hours. Subgrouped after way of commuting.

    Measured: 6 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2022
  2. Study start15 Sep 2022
  3. Primary completion30 Sep 2022
  4. Study completion15 Nov 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (actual)
Target duration
6 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT05507944
Sponsor's protocol ID
22/16786
Status last verified
Aug 2022
First submitted
17 Aug 2022
Last updated
6 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Occupational Exposure and Environmental Exposure, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Daily FeNO (ppb measured by Niox Vero) increase after occupational exposure. (time frame: 1 day.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in